马来西亚诊所启动了IVA生育治疗,增加了卵巢保留量低的妇女的活产机会。 Malaysia clinic launches IVA fertility treatment, boosting live birth chances for women with low ovarian reserve.

马来西亚的Thomson生育率正在启动体外活化(IVA),这是一种新的生育治疗方法,为拥有初级Ovarian营养不良或卵巢储备减少的妇女带来希望。 Thomson Fertility in Malaysia is launching In-Vitro Activation (IVA), a new fertility treatment offering hope to women with Primary Ovarian Insufficiency or diminished ovarian reserves. 该程序涉及在被除去的卵巢组织中激活休眠卵囊并重新植入,有可能将活产率从大约5%提高到20%。 The procedure involves activating dormant follicles in removed ovarian tissue and re-implanting it, potentially increasing live birth rates from about 5% to up to 20%. 由日本川村和弘博士(Kazuhiro Kawamura)开发的IVA允许女性在传统IVF不可行时使用自己的卵。 Developed by Dr. Kazuhiro Kawamura of Japan, IVA allows women to use their own eggs when traditional IVF isn’t viable. 该诊所由Prasanna Supramaniam博士领导,以1994年以来8 000多名IVF婴儿的遗产为基础,强调病人的教育和就医机会。 Led by Dr. Prasanna Supramaniam, the clinic emphasizes patient education and access, building on its legacy of over 8,000 IVF babies since 1994. 对于寻求文化上一致的生育率选择的穆斯林妇女来说,这种治疗尤其重要。 The treatment is especially significant for Muslim women seeking culturally aligned fertility options.